185 related articles for article (PubMed ID: 36578176)
1. Characterisation of a novel transcript LNPPS acting as tumour suppressor in bladder cancer via PDCD5-mediated p53 degradation blockage.
Li J; Wang Y; Zhang X; Yang X; Qi Q; Mi Q; Feng M; Wang Y; Wang C; Li P; Du L
Clin Transl Med; 2023 Jan; 13(1):e1149. PubMed ID: 36578176
[TBL] [Abstract][Full Text] [Related]
2. PDCD5 interacts with p53 and functions as a positive regulator in the p53 pathway.
Xu L; Hu J; Zhao Y; Hu J; Xiao J; Wang Y; Ma D; Chen Y
Apoptosis; 2012 Nov; 17(11):1235-45. PubMed ID: 22914926
[TBL] [Abstract][Full Text] [Related]
3. DNAJB1 destabilizes PDCD5 to suppress p53-mediated apoptosis.
Cui X; Choi HK; Choi YS; Park SY; Sung GJ; Lee YH; Lee J; Jun WJ; Kim K; Choi KC; Yoon HG
Cancer Lett; 2015 Feb; 357(1):307-315. PubMed ID: 25444898
[TBL] [Abstract][Full Text] [Related]
4. LncRNA PVT1 contributes to invasion and doxorubicin resistance of bladder cancer cells through promoting MDM2 expression and AURKB-mediated p53 ubiquitination.
Jiang X; Li H; Fang Y; Xu C
Environ Toxicol; 2022 Jun; 37(6):1495-1508. PubMed ID: 35213076
[TBL] [Abstract][Full Text] [Related]
5. Deubiquitinase OTUD5 mediates the sequential activation of PDCD5 and p53 in response to genotoxic stress.
Park SY; Choi HK; Choi Y; Kwak S; Choi KC; Yoon HG
Cancer Lett; 2015 Feb; 357(1):419-427. PubMed ID: 25499082
[TBL] [Abstract][Full Text] [Related]
6. Programmed cell death 5 mediates HDAC3 decay to promote genotoxic stress response.
Choi HK; Choi Y; Park ES; Park SY; Lee SH; Seo J; Jeong MH; Jeong JW; Jeong JH; Lee PC; Choi KC; Yoon HG
Nat Commun; 2015 Jun; 6():7390. PubMed ID: 26077467
[TBL] [Abstract][Full Text] [Related]
7. The p53 binding protein PDCD5 is not rate-limiting in DNA damage induced cell death.
Bock FJ; Tanzer MC; Haschka MD; Krumschnabel G; Sohm B; Goetsch K; Kofler R; Villunger A
Sci Rep; 2015 Jun; 5():11268. PubMed ID: 26062895
[TBL] [Abstract][Full Text] [Related]
8. Lgr5-mediated p53 Repression through PDCD5 leads to doxorubicin resistance in Hepatocellular Carcinoma.
Ma Z; Guo D; Wang Q; Liu P; Xiao Y; Wu P; Wang Y; Chen B; Liu Z; Liu Q
Theranostics; 2019; 9(10):2967-2983. PubMed ID: 31244936
[TBL] [Abstract][Full Text] [Related]
9. Transfection of PDCD5 effect on the biological behavior of tumor cells and sensitized gastric cancer cells to cisplatin-induced apoptosis.
Xu HY; Chen ZW; Pan YM; Fan L; Guan J; Lu YY
Dig Dis Sci; 2012 Jul; 57(7):1847-56. PubMed ID: 22359193
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA CDR1as disrupts the p53/MDM2 complex to inhibit Gliomagenesis.
Lou J; Hao Y; Lin K; Lyu Y; Chen M; Wang H; Zou D; Jiang X; Wang R; Jin D; Lam EW; Shao S; Liu Q; Yan J; Wang X; Chen P; Zhang B; Jin B
Mol Cancer; 2020 Sep; 19(1):138. PubMed ID: 32894144
[TBL] [Abstract][Full Text] [Related]
11. The von Hippel-Lindau tumor suppressor regulates programmed cell death 5-mediated degradation of Mdm2.
Essers PB; Klasson TD; Pereboom TC; Mans DA; Nicastro M; Boldt K; Giles RH; MacInnes AW
Oncogene; 2015 Feb; 34(6):771-9. PubMed ID: 24469044
[TBL] [Abstract][Full Text] [Related]
12. Serine/threonine kinase 31 promotes PDCD5-mediated apoptosis in p53-dependent human colon cancer cells.
Kwak S; Lee SH; Han EJ; Park SY; Jeong MH; Seo J; Park SH; Sung GJ; Yoo JY; Yoon HG; Choi KC
J Cell Physiol; 2019 Mar; 234(3):2649-2658. PubMed ID: 30144069
[TBL] [Abstract][Full Text] [Related]
13. Programmed cell death 5 improves skeletal muscle insulin resistance by inhibiting IRS-1 ubiquitination through stabilization of MDM2.
Li B; Ye J; Liu R; Weng L; Cao Y; Jia S; Xu C; Liu Y; Yan S; Zheng M
Life Sci; 2021 Nov; 285():119918. PubMed ID: 34480939
[TBL] [Abstract][Full Text] [Related]
14. PDCD5 functions as a regulator of p53 dynamics in the DNA damage response.
Zhuge C; Sun X; Chen Y; Lei J
J Theor Biol; 2016 Jan; 388():1-10. PubMed ID: 26433055
[TBL] [Abstract][Full Text] [Related]
15. YAF2 promotes TP53-mediated genotoxic stress response via stabilization of PDCD5.
Park SY; Choi HK; Jo SH; Seo J; Han EJ; Choi KC; Jeong JW; Choi Y; Yoon HG
Biochim Biophys Acta; 2015 May; 1853(5):1060-72. PubMed ID: 25603536
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA XIST participates in bladder cancer by downregulating p53 via binding to TET1.
Hu B; Shi G; Li Q; Li W; Zhou H
J Cell Biochem; 2019 Apr; 120(4):6330-6338. PubMed ID: 30362292
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA LOC572558 inhibits bladder cancer cell proliferation and tumor growth by regulating the AKT-MDM2-p53 signaling axis.
Zhu Y; Dai B; Zhang H; Shi G; Shen Y; Ye D
Cancer Lett; 2016 Oct; 380(2):369-374. PubMed ID: 27130667
[TBL] [Abstract][Full Text] [Related]
18. Blockage of MDM2-mediated p53 ubiquitination by yuanhuacine restrains the carcinogenesis of prostate carcinoma cells by suppressing LncRNA LINC00665.
Yan M; Li X; Gu J; Gao G; Wu Z; Xue P
J Biochem Mol Toxicol; 2023 Mar; 37(3):e23265. PubMed ID: 36416364
[TBL] [Abstract][Full Text] [Related]
19. OTU deubiquitinase 5 inhibits the progression of non-small cell lung cancer via regulating p53 and PDCD5.
Kang XY; Zhang J; Tang L; Huang L; Tong J; Fu Q
Chem Biol Drug Des; 2020 Aug; 96(2):790-800. PubMed ID: 32248621
[TBL] [Abstract][Full Text] [Related]
20. PDCD5 interacts with Tip60 and functions as a cooperator in acetyltransferase activity and DNA damage-induced apoptosis.
Xu L; Chen Y; Song Q; Xu D; Wang Y; Ma D
Neoplasia; 2009 Apr; 11(4):345-54. PubMed ID: 19308289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
